BLAUVELT, A.; WARREN, R.; REICH, K.; BROCK, F.; FIERENS, F.; CIARAVINO, V.; LEBWOHL, M. Durability of DLQI Improvements Among Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 1, p. s19, 2021. DOI: 10.25251/skin.5.supp.19. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/1172. Acesso em: 4 jul. 2024.